Blackhall F - Search Results

1

REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.

Ghorani E, Quartagno M, Blackhall F, Gilbert DC, O'Brien M, Ottensmeier C, Pizzo E, Spicer J, Williams A, Badman P, Parmar MKB, Seckl MJ; REFINE-Lung Investigators. Ghorani E, et al. Among authors: blackhall f. Lancet Oncol. 2023 May;24(5):e219-e227. doi: 10.1016/S1470-2045(23)00095-5. Lancet Oncol. 2023. PMID: 37142383 Review.

2

Where next for gefitinib in patients with lung cancer?

Blackhall F, Ranson M, Thatcher N. Blackhall F, et al. Lancet Oncol. 2006 Jun;7(6):499-507. doi: 10.1016/S1470-2045(06)70725-2. Lancet Oncol. 2006. PMID: 16750500 Review.

3

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.

Baka S, Califano R, Ferraldeschi R, Aschroft L, Thatcher N, Taylor P, Faivre-Finn C, Blackhall F, Lorigan P. Baka S, et al. Among authors: blackhall f. Br J Cancer. 2008 Aug 5;99(3):442-7. doi: 10.1038/sj.bjc.6604480. Br J Cancer. 2008. PMID: 18665190 Free PMC article. Clinical Trial.

4

Targeting blood vessels for the treatment of non-small cell lung cancer.

Amir E, Hughes S, Blackhall F, Thatcher N, Ostoros G, Timar J, Tovari J, Kovacs G, Dome B. Amir E, et al. Among authors: blackhall f. Curr Cancer Drug Targets. 2008 Aug;8(5):392-403. doi: 10.2174/156800908785133187. Curr Cancer Drug Targets. 2008. PMID: 18690845 Review.

5

Antivascular agents for non-small-cell lung cancer: current status and future directions.

Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B. Amir E, et al. Among authors: blackhall f. Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86. doi: 10.1517/13543780903336050. Expert Opin Investig Drugs. 2009. PMID: 19877762 Review.

6

A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer.

Blackhall FH, O'brien M, Schmid P, Nicolson M, Taylor P, Milenkova T, Kennedy SJ, Thatcher N. Blackhall FH, et al. J Thorac Oncol. 2010 Aug;5(8):1285-8. doi: 10.1097/JTO.0b013e3181e3a2d1. J Thorac Oncol. 2010. PMID: 20661087 Free article. Clinical Trial.

7

Treatment of limited small cell lung cancer: an old or new challenge?

Blackhall F, Faivre-Finn C. Blackhall F, et al. Curr Opin Oncol. 2011 Mar;23(2):158-62. doi: 10.1097/CCO.0b013e328341ee4d. Curr Opin Oncol. 2011. PMID: 21107256 Review.

8

Understanding cough and its management in lung cancer.

Harle AS, Blackhall FH, Smith JA, Molassiotis A. Harle AS, et al. Curr Opin Support Palliat Care. 2012 Jun;6(2):153-62. doi: 10.1097/SPC.0b013e328352b6a5. Curr Opin Support Palliat Care. 2012. PMID: 22469666 Review.

9

How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?

Bayman N, Blackhall F, McCloskey P, Taylor P, Faivre-Finn C. Bayman N, et al. Among authors: blackhall f. Lung Cancer. 2014 Feb;83(2):117-25. doi: 10.1016/j.lungcan.2013.11.017. Epub 2013 Dec 1. Lung Cancer. 2014. PMID: 24373738 Review.

10

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.

Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, O'Brien M, Stone P, Benepal T, Bates N, Wee B. Spathis A, et al. Among authors: blackhall f. J Clin Oncol. 2014 Jun 20;32(18):1882-8. doi: 10.1200/JCO.2013.54.4346. Epub 2014 Apr 28. J Clin Oncol. 2014. PMID: 24778393 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page